ESPE Abstracts (2022) 95 P1-220

ESPE2022 Poster Category 1 Bone, Growth Plate and Mineral Metabolism (46 abstracts)

Hypocalcemia as the Initial Presentation of Type2 Bartter Syndrome: A Family Report

Shira London 1,2 , Michael A. Levine 3 , Dong Li 4 , Ronen Spiegel 5,6 , Asaf Lebel 6,7 & Yardena Tenenbaum-Rakover 1,6

1Pediatric Endocrine Institute, Ha’Emek Medical Center, Afula, Israel; 2Armon Child Health Center, Clalit Health Services, Haifa, Israel; 3Division of Endocrinology and Diabetes, Center for Bone Health, The Children’s Hospital of Philadelphia, Philadelphia, USA; 4Center for Applied Genomics, The Children’s Hospital of Philadelphia, Philadelphia, USA; 5Pediatric Ward B, Ha’Emek Medical Center, Afula, Israel; 6The Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel; 7Pediatric Nephrology Unit, Ha’Emek Medical Center, Afula, Israel

Context: Bartter syndrome (BS) is a group of rare autosomal-recessive tubulopathies characterized by hypokalemic, hypochloremic metabolic alkalosis in which the primary defect is a deficiency of transporters involved in sodium chloride reabsorption. Type 2 BS results from a defect in the renal outer medullary potassium channel encoded by the KCNJ1 gene. Type 2 BS presents with polyhydramnios, intrauterine growth retardation, prematurity, failure to thrive, polyuria, hypercalciuria, and life-threatening episodes of dehydration. Hypocalcemia is a very rare presenting symptom of BS, with only a few published cases reporting it as the initial manifestation of type 2 BS.

Objective: To describe a child who presented with hypocalcemic seizure at the age of 2.3 years that was first related to vitamin D deficiency and high-phosphate soft drink consumption.

Methods: Whole exome sequencing (WES) was used to evaluate the biochemical abnormalities of the proband.

Results: We identified a previously described homozygous missense mutation c.212C>T, p.T71M in the KCNJ1 gene associated with type 2 BS. Six additional family members with the same mutation and diagnosed clinically with BS are also reported, 2 presenting with hypocalcemia associated with vitamin D deficiency.

Conclusion: This report expands the clinical spectrum associated with KCNJ1 mutations and emphasizes the role of WES in unsolved cases of hypocalcemia when genetic disease is suspected. It also highlights the hazardous effects of phosphate-containing soft drinks on calcium metabolism.

Volume 95

60th Annual ESPE (ESPE 2022)

Rome, Italy
15 Sep 2022 - 17 Sep 2022

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.